TESTIMONY AND CORRESPONDENCE
SWHR sent a letter to Administrator Oz requesting that the Centers for Medicare and Medicaid Services (CMS) reconsider the provisions included under the CMS Contract Year 2026 Medicare Advantage and Part D Proposed Rule addressing coverage of anti-obesity medications.